Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Klink

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Targeted Oncology|June 18, 2022
Timing of NTRK Gene Fusion Testing and Treatment Modifications Following TRK Fusion Status Among US Oncologists Treating TRK Fusion CancerAndrew J Klink, Abhishek Kavati, Awa T Gassama, et al.
Journal of Managed Care & Specialty Pharmacy|April 5, 2019
Health Care Resource Utilization and Costs in First-Line Treatments for Patients with Metastatic Melanoma in the United StatesAndrew J Klink, Bartosz Chmielowski, Bruce Feinberg, et al.
Water Environment Research : a Research Publication of the Water Environment Federation|August 1, 2020
A comparative study of acid-treated, base-treated, and Fenton-like reagent-treated biomass for Cr(VI) sequestration from aqueous solutionsObakeng B Nchoe, Themba D Ntuli, Michael J Klink, et al.
Bioinorganic Chemistry and Applications|June 1, 2018
Adsorptive Removal of Hexavalent Chromium by Diphenylcarbazide-Grafted <i>Macadamia</i> Nutshell PowderLondolani C Maremeni, Sekomeng J Modise, Fanyana M Mtunzi, et al.
The Oncologist|March 11, 2022
Real-world Treatment Patterns and Reasons for Therapy Selection in Patients with Advanced Hepatocellular Carcinoma in US Oncology PracticesAndrew J Klink, Landon Z Marshall, Abdalla Aly, et al.
Human Vaccines & Immunotherapeutics|April 7, 2016
Economic burden of hepatitis B infection among patients with diabetesGaurav Deshpande, Andrew J Klink, Rahul Shenolikar, et al.
Leukemia Research|September 15, 2022
Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemiaAndrew J Klink, Ajeet Gajra, Russell L Knoth, et al.
Talanta|October 31, 2008
The use of X-ray fluorescence (XRF) analysis in predicting the alkaline hydrothermal conversion of fly ash precipitates into zeolitesV S Somerset, L F Petrik, R A White, et al.
Journal of Geriatric Oncology|August 17, 2020
Real-world adverse events associated with CAR T-cell therapy among adults age ≥ 65 yearsMarjorie E Zettler, Bruce A Feinberg, Eli G Phillips, et al.
Leukemia Research|January 10, 2024
Corrigendum to "Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia" [Leuk. Res. (2022) 106946]Andrew J Klink, Ajeet Gajra, Russell L Knoth, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Targeted Oncology|June 18, 2022
Timing of NTRK Gene Fusion Testing and Treatment Modifications Following TRK Fusion Status Among US Oncologists Treating TRK Fusion CancerAndrew J Klink, Abhishek Kavati, Awa T Gassama, et al.
Journal of Managed Care & Specialty Pharmacy|April 5, 2019
Health Care Resource Utilization and Costs in First-Line Treatments for Patients with Metastatic Melanoma in the United StatesAndrew J Klink, Bartosz Chmielowski, Bruce Feinberg, et al.
Water Environment Research : a Research Publication of the Water Environment Federation|August 1, 2020
A comparative study of acid-treated, base-treated, and Fenton-like reagent-treated biomass for Cr(VI) sequestration from aqueous solutionsObakeng B Nchoe, Themba D Ntuli, Michael J Klink, et al.
Bioinorganic Chemistry and Applications|June 1, 2018
Adsorptive Removal of Hexavalent Chromium by Diphenylcarbazide-Grafted <i>Macadamia</i> Nutshell PowderLondolani C Maremeni, Sekomeng J Modise, Fanyana M Mtunzi, et al.
The Oncologist|March 11, 2022
Real-world Treatment Patterns and Reasons for Therapy Selection in Patients with Advanced Hepatocellular Carcinoma in US Oncology PracticesAndrew J Klink, Landon Z Marshall, Abdalla Aly, et al.
Human Vaccines & Immunotherapeutics|April 7, 2016
Economic burden of hepatitis B infection among patients with diabetesGaurav Deshpande, Andrew J Klink, Rahul Shenolikar, et al.
Leukemia Research|September 15, 2022
Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemiaAndrew J Klink, Ajeet Gajra, Russell L Knoth, et al.
Talanta|October 31, 2008
The use of X-ray fluorescence (XRF) analysis in predicting the alkaline hydrothermal conversion of fly ash precipitates into zeolitesV S Somerset, L F Petrik, R A White, et al.
Journal of Geriatric Oncology|August 17, 2020
Real-world adverse events associated with CAR T-cell therapy among adults age ≥ 65 yearsMarjorie E Zettler, Bruce A Feinberg, Eli G Phillips, et al.
Leukemia Research|January 10, 2024
Corrigendum to "Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia" [Leuk. Res. (2022) 106946]Andrew J Klink, Ajeet Gajra, Russell L Knoth, et al.
Pageof 6